CellaVision AB
OTC:CLVSF

Watchlist Manager
CellaVision AB Logo
CellaVision AB
OTC:CLVSF
Watchlist
Price: 15.85 USD Market Closed
Market Cap: $378m

Profitability Summary

CellaVision AB's profitability score is 59/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

59/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

59/100
Profitability
Score
59/100
Profitability
Score

Margins

Earnings Waterfall
CellaVision AB

Margins Comparison
CellaVision AB Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
SE
CellaVision AB
STO:CEVI
3.6B SEK
Loading...
Loading...
Loading...
US
Abbott Laboratories
NYSE:ABT
202.2B USD
Loading...
Loading...
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
178.4B USD
Loading...
Loading...
Loading...
US
Stryker Corp
NYSE:SYK
148B USD
Loading...
Loading...
Loading...
IE
Medtronic PLC
NYSE:MDT
124.9B USD
Loading...
Loading...
Loading...
US
Boston Scientific Corp
NYSE:BSX
113.5B USD
Loading...
Loading...
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.8B EUR
Loading...
Loading...
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
52.7B USD
Loading...
Loading...
Loading...
US
Becton Dickinson and Co
NYSE:BDX
50.3B USD
Loading...
Loading...
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
50.3B USD
Loading...
Loading...
Loading...
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.3B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
CellaVision AB Competitors

Country Company Market Cap ROE ROA ROCE ROIC
SE
CellaVision AB
STO:CEVI
3.6B SEK
Loading...
Loading...
Loading...
Loading...
US
Abbott Laboratories
NYSE:ABT
202.2B USD
Loading...
Loading...
Loading...
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
178.4B USD
Loading...
Loading...
Loading...
Loading...
US
Stryker Corp
NYSE:SYK
148B USD
Loading...
Loading...
Loading...
Loading...
IE
Medtronic PLC
NYSE:MDT
124.9B USD
Loading...
Loading...
Loading...
Loading...
US
Boston Scientific Corp
NYSE:BSX
113.5B USD
Loading...
Loading...
Loading...
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
47.8B EUR
Loading...
Loading...
Loading...
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
52.7B USD
Loading...
Loading...
Loading...
Loading...
US
Becton Dickinson and Co
NYSE:BDX
50.3B USD
Loading...
Loading...
Loading...
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
50.3B USD
Loading...
Loading...
Loading...
Loading...
US
GE Healthcare Technologies Inc
NASDAQ:GEHC
38.3B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
CellaVision AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett